Rodolphe Clerval

Rodolphe Clerval

Company: COAVE THERAPEUTICS

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Discovering Novel Technology for CNS Disorders 5:00 pm

What are the newer procedures for capsid screening platforms for tissue and cell tropism? Which vectors are showing clinical progress? Are there novel vectors showing CNS tropism and selectivity in NHPs? What are the respective challenges for different vector types?Read more

day: Day One

Discussing AAV-ligand Conjugates for Improved Efficacy & Distribution in CNS 4:00 pm

CNS delivery of gene therapy products remains challenging, in particular for achieving deep brain distribution of genetic materials Chemical modification of AAV by new conjugation chemistry enables a rapid generation of rationally designed capsids Generation of several conjugated AAV (coAAV) with improved in vivo transduction and biodistribution propertiesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.